In episode 313, James and Mike go over two new large COPD trials that looked at the use of different types of inhalers and find that unfortunately they do very little to clinically relevant outcomes. The bottom line is don’t smoke.
Show notes
1) SUMMIT trial - Fluticasone furoate and vilanterol
